Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,825 All time
- Disclosed funding
- $368.7B 3770 disclosed amounts
- Median round
- $14.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SystemCompany profile An online care platform connects patients with licensed clinicians for personalized health assessments and prescribed treatments. An online care platform connects patients with licensed clinicians for personalized health assessments and prescribed treatments. | $20M | FundingUndisclosed | Healthtech | United States | Investors | |
| W WintCompany profile An AI water-intelligence system detects leaks and waste across buildings and can shut off water before damage spreads. An AI water-intelligence system detects leaks and waste across buildings and can shut off water before damage spreads. | $36M | Series DSeries C+ | Climate tech | United States | Investors | |
AERLINCompany profile A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools. A Berlin aviation startup developing a more efficient flying-wing aircraft platform, beginning with a two-seat ultralight for private pilots and flight schools. | Undisclosed | Seed | Mobility | Germany | Investors | |
ImplicityCompany profile Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices. Implicity provides AI-powered remote cardiac monitoring and data-management software that helps care teams interpret information from implanted heart devices. | €35M | Growth equityGrowth | Healthtech | France | Investors | |
| II Interbeing, Inc.Company profile Voice-analysis software and coaching that help sales teams assess delivery and HR teams monitor employee wellbeing. Voice-analysis software and coaching that help sales teams assess delivery and HR teams monitor employee wellbeing. | ~¥50M | FundingUndisclosed | AI | Japan | Investors | |
HVR EnergyCompany profile HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. | €20M | Series A | Mobility | Spain | Investors | |
| A AquaCompany profile Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. | $15M | Series A | Fintech | United States | Investors | |
MCatalysisCompany profile MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers. MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers. | $5M | Seed | Climate tech | United Kingdom | Investors | |
| H Provides legal infrastructure for law firms and in-house teams | $550M | Series HSeries C+ | AI | United States | Investors | |
| A AllogeneticsCompany profile Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. | €3.8M | Pre-Series ASeries A | Biotech | Germany | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
162rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
115rounds22led - 3General Catalyst
Matiks, Provision Labs, Tractian
105rounds15led - 4Lightspeed
Warp Sciences, Different, Zenzap
82rounds9led - 5Sequoia Capital
Nevis, Warhound, Whop
72rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →